Publicación:
Determinación de marcadores inflamatorios y anabólicos articulares en caballos jóvenes estabulados con osteocondrosis tarsocrural

Vista sencilla de ítem
dc.contributor.authorCarmona, Jorgespa
dc.contributor.authorLópez, Catalinaspa
dc.contributor.authorPrades, Martaspa
dc.date.accessioned2010-01-01 00:00:00
dc.date.accessioned2022-07-01T20:59:05Z
dc.date.available2010-01-01 00:00:00
dc.date.available2022-07-01T20:59:05Z
dc.date.issued2009-01-01
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.21897/rmvz.328
dc.identifier.eissn1909-0544
dc.identifier.issn0122-0268
dc.identifier.urihttps://repositorio.unicordoba.edu.co/handle/ucordoba/5549
dc.identifier.urlhttps://doi.org/10.21897/rmvz.328
dc.language.isospaspa
dc.publisherUniversidad de Córdobaspa
dc.relation.bitstreamhttps://revistamvz.unicordoba.edu.co/article/download/328/396
dc.relation.citationeditionNúm. 1 , Año 2010 : Revista MVZ Córdoba Volumen 15(1) Enero-Abril 2010spa
dc.relation.citationissue1spa
dc.relation.citationvolume15spa
dc.relation.ispartofjournalRevista MVZ Córdobaspa
dc.relation.referencesMcIlwraith CW. Clinical aspects of osteochondritis dissecans. In: McIlwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996; 369-374.spa
dc.relation.referencesWittwer C, Hamann H, Rosenberger E, Distl O. Prevalence of osteochondrosis in the limb joints of South German Coldblood horses. J Vet Med A Physiol Pathol Clin Med 2006; 53: 531-539. http://dx.doi.org/10.1111/j.1439-0442.2006.00881.xspa
dc.relation.referencesJeffcot LB. Osteochondrosis: an international problem for the horse industry. J Equine Vet Scien 1996; 16: 32-37. http://dx.doi.org/10.1016/S0737-0806(96)80063-3spa
dc.relation.referencesVan Weeren PR. Etiology, diagnosis and treatment of OC(D). Clin Tech Equine Pract 2006; 5: 248-258. http://dx.doi.org/10.1053/j.ctep.2006.08.002spa
dc.relation.referencesde Grauw JC, Brama PA, Wiemer P, Brommer H, van de Lest CH, van Weeren PR. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia. Am J Vet Res 2006; 67: 1156-1162. http://dx.doi.org/10.2460/ajvr.67.7.1156spa
dc.relation.referencesGangl M, Serteyn D, Lejeune JP, Schneider N, Grulke S, Peters F, et al. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Res Vet Sci 2007;82:68-75. http://dx.doi.org/10.1016/j.rvsc.2006.03.008spa
dc.relation.referencesSutton S, Clutterbuck A, Harris P, Gent T, Freeman S, Foster N, et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 2009; 179:10-24. http://dx.doi.org/10.1016/j.tvjl.2007.08.013spa
dc.relation.referencesCarmona JU, Prades, M. Pathophysiology of osteoarthritis. Comp Equine 2009; 4: 28-40.spa
dc.relation.referencesHoward RD, McIIwraith CW: Hyaluronan and its use in the treatment of equine joint disease. In McIIwraith CW, Trotter GW (eds). Joint disease in the horse. Philadelphia: WB Saunders Company; 1996.spa
dc.relation.referencesPopot MA, Bonnaire J, Guéchot J, et al. Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration. Equine Vet J 2004; 36:482-487. http://dx.doi.org/10.2746/0425164044877350spa
dc.relation.referencesFrean SP, Abraham LA, Lees P: In vitro stimulation of equine articular cartilage proteoglycans synthesis by hyaluronan and carprofen. Res Vet Sci 1999; 67:181-188.spa
dc.relation.referencesCarmona JU, Argüelles D, Climent F, Prades M. Autologous platelet concentrates as a treatment of horses with osteoarthritis: A preliminary pilot clinical study. J Equine Vet Scien 2007; 4: 167-170. http://dx.doi.org/10.1016/j.jevs.2007.02.007spa
dc.relation.referencesAmerican association of equine practitioners (AAEP). Guide for veterinary service and judging of equestrian events: definition and classification of lameness. AAEP 1991.spa
dc.relation.referencesVon Rechemberg B, McIlwraith CW, Akens MK, Frisbie DD, Leutenegger C, Auer JA. Spontaneous production of nitric oxide (NO), prostaglandin (PGE2), and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints. Equine Vet J 2000; 32:140-150. http://dx.doi.org/10.2746/042516400777591598spa
dc.relation.referencesBertone AL, Palmer JL. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg 2001; 30:528-538. http://dx.doi.org/10.1053/jvet.2001.28430spa
dc.relation.referencesArcher S. Measurement of Nitric Oxide in biological models. FASEB J 1993; 7:340-360.spa
dc.relation.referencesCarmona JU, D Argüelles, M Prades. Niveles de factor de crecimiento transformante beta-3 y óxido nítrico en cuatro concentrados autólogos de plaquetas y plasma derivados de sangre equina. Arch Med Vet 2008; 40: 155-160. http://dx.doi.org/10.4067/S0301-732X2008000200007spa
dc.relation.referencesGuechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42: 558-63.spa
dc.relation.referencesLappegård KT, Riesenfeld J, Brekke OL et al. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. Ann Thorac Surg 2005; 79: 917-923. http://dx.doi.org/10.1016/j.athoracsur.2004.08.015spa
dc.relation.referencesVan den Boom R, van de Lest CH, Bull S, et al. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J 2005; 37: 250-256. http://dx.doi.org/10.2746/0425164054530740spa
dc.relation.referencesViitanen M, Bird J, Maisi P, et al. Differences in the concentration of various synovial fluid constituents between the distal interphalangeal joint, the metacarpophalangeal joint and the navicular bursa in normal horses. Res Vet Sci 2000; 69:63-67 http://dx.doi.org/10.1053/rvsc.2000.0385spa
dc.relation.referencesPopot MA, Bonnaire Y, Guéchot J, Toutain PL. Hyaluronan in horses: physiological production rate, plasma and synovial fluid concentrations in control conditions and following sodium hyaluronate administration. Equine Vet J 2004; 36: 482-487. http://dx.doi.org/10.2746/0425164044877350spa
dc.relation.referencesTaylor SE, Weaver MP, Pitsillides AA, Wheeler BT, Wheeler-Jones CP, Shaw DJ, Smith RK. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. Equine Vet J 2006; 38:502-507. http://dx.doi.org/10.2746/042516406X156073spa
dc.relation.referencesTulamo RM, Houttu J, Tupam&ai A, Salonen M Hyaluronate and large molecular weight proteoglycans in synovial fluid from horses with various arthritides. Am J Vet Res 1996; 57:932-7.spa
dc.relation.referencesViitanen M, Bird J, Makela O, Schramme M, Smith R, Tulamo RM, May S. Synovial fluid studies in navicular disease. Res Vet Sci 2001; 71:201-206. http://dx.doi.org/10.1053/rvsc.2001.0509spa
dc.relation.referencesBrown MP, Trumble TN, Plaas AH, Sandy JD, Romano M, Hernandez J, Merritt KA. Exercise and injury increase chondroitin sulfate chain length and decrease hyaluronan chain length in synovial fluid. Osteoarthritis Cartilage 2007; 15:1318-1325. http://dx.doi.org/10.1016/j.joca.2007.04.005spa
dc.relation.referencesPitsillides AA, Worrall JG, Wilkinson LS, Bayliss MT, Edwards JC. Hyaluronan concentration in non-inflamed and rheumatoid synovium. Br J Rheumatol 1994; 33:5-10. http://dx.doi.org/10.1093/rheumatology/33.1.5spa
dc.relation.referencesKawcak CE, Frisbie DD, Trotter GW, McIlwraith CW, Gillette SM, Powers BE, Walton RM. Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res 1997;58:1132-40.spa
dc.relation.referencesMartínez-Puig D, Carmona JU, Argüelles D, Deulofeu R, Ubia A, Prades M. Oral hyaluronic acid administration improves osteochondrosis clinical symptoms and slightly increses intraarticular concentration of hyaluronic acid in a horse model: a pilot survey [resumen]. Osteoarthritis Cartilage 2007; 15:C62-C63.spa
dc.relation.referencesBergin BJ, Pierce SW, Bramlage LR, Stromberg A. Oral hyaluronan gel reduces post operative tarsocrural effusion in the yearling Thoroughbred. Equine Vet J 2006; 38: 375-8. http://dx.doi.org/10.2746/042516406777749218spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistamvz.unicordoba.edu.co/article/view/328spa
dc.subjectEquinesspa
dc.subjectosteochondrosisspa
dc.subjectjoint biomarkersspa
dc.titleDeterminación de marcadores inflamatorios y anabólicos articulares en caballos jóvenes estabulados con osteocondrosis tarsocruralspa
dc.title.translatedDeterminación de marcadores inflamatorios y anabólicos articulares en caballos jóvenes estabulados con osteocondrosis tarsocruraleng
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication
Archivos
Colecciones
HAJ. Revista MVZ